Bank of New York Mellon’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bank of New York Mellon’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-87,615	Closed	-$8.79M	–	4396
2015 Q1	$8.79M	Sell	87,615 -119,862	-58%	-$7.98M	﹤0.01%	2011
2014 Q4	$10.9M	Buy	207,477 +77,467	+60%	+$2.27M	﹤0.01%	1865
2014 Q3	$3.34M	Buy	130,010 +98,241	+309%	+$2.09M	﹤0.01%	2550
2014 Q2	$708K	Sell	31,769 -154,571	-83%	-$3.38M	﹤0.01%	3493
2014 Q1	$5.73M	Buy	+186,340	New	+$5.01M	﹤0.01%	2240

Bank of New York Mellon's ASPX Position: Q2 2015 in Review

Bank of New York Mellon sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 87,615 shares — an estimated $8.79M sold.

Bank of New York Mellon first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $10.9M in Q4 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Bank of New York Mellon reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Bank of New York Mellon sold 87,615 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $8.79M.
Bank of New York Mellon first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
Bank of New York Mellon's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $10.9M in Q4 2014.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Bank of New York Mellon's 13F filing for Q2 2015, filed 6 Aug 2015.